AscoTop Nasal 5 mg/Dosis Nasenspray

AscoTop Nasal 5 mg/Dosis Nasenspray is a nasal spray medication used for the acute treatment of migraine attacks. The active ingredient is zolmitriptan, a selective serotonin (5-HT1) agonist that constricts blood vessels in the brain to alleviate migraine symptoms. The product is manufactured in multiple countries, with AstraZeneca, a British-Swedish multinational pharmaceutical company headquartered in Cambridge, UK, being the ultimate owner. AstraZeneca specializes in the development and manufacturing of prescription medicines, including treatments for cardiovascular, respiratory, and oncology conditions. The brand was originally developed by AstraZeneca in the United Kingdom and continues to be owned and marketed by the company.